Hadipour E et al [19] found that VK2 has anti-apoptosis and anti-oxidation effects, and suggested that VK2 may be a valuable protective candidate to prevent the progression of Alzheimer's disease by inactivating p38 MAP kinase pathway. This evidence concerns the gene MAPK14 and early-onset autosomal dominant Alzheimer disease.